Alkem Laboratories (NSE:ALKEM) 3-Year Book Growth Rate : 13.70% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories 3-Year Book Growth Rate?

Alkem Laboratories's Book Value per Share for the quarter that ended in Dec. 2023 was ₹0.00.

During the past 12 months, Alkem Laboratories's average Book Value per Share Growth Rate was 7.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was 13.70% per year. During the past 5 years, the average Book Value per Share Growth Rate was 14.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Alkem Laboratories was 25.30% per year. The lowest was 11.30% per year. And the median was 16.00% per year.

Competitive Comparison of Alkem Laboratories's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alkem Laboratories's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's 3-Year Book Growth Rate falls into.

Alkem Laboratories 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Alkem Laboratories (NSE:ALKEM) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Alkem Laboratories 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Alkem Laboratories (NSE:ALKEM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

539523:India

Address

Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.alkemlabs.com

Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines